Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modeled analysis.

@article{Howard2010CosteffectivenessOS,
  title={Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modeled analysis.},
  author={Kirsten Howard and Sarah White and Glenn Salkeld and S Mcdonald and Jonathan C Craig and Steven J Chadban and Alan Cass},
  journal={Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research},
  year={2010},
  volume={13 2},
  pages={196-208}
}
OBJECTIVES Chronic kidney disease is, increasingly, both a contributor to premature deaths and a financial burden to the health system, and is estimated to affect between 10% and 15% of the adult population in Western countries. Hypertension and, in particular diabetes, are significant contributors to the global burden of chronic kidney disease. Although it might increase costs, screening for, and improved management of, persons at increased risk of progressive kidney disease could improve… CONTINUE READING